These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31502562)

  • 1. Biopolymers augment viral vectors based gene delivery.
    Balakrishnan B; David E
    J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV6 Vector Production and Purification for Muscle Gene Therapy.
    Halbert CL; Allen JM; Chamberlain JS
    Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hybrid-vectors for delivery of autonomous replicons.
    Zhang W; Hagedorn C; Schulz E; Lipps HJ; Ehrhardt A
    Curr Gene Ther; 2014 Feb; 14(1):10-23. PubMed ID: 24365145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.
    Lipshutz GS; Gruber CA; Cao Y ; Hardy J; Contag CH; Gaensler KM
    Mol Ther; 2001 Mar; 3(3):284-92. PubMed ID: 11273769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors.
    Vassalli G; Büeler H; Dudler J; von Segesser LK; Kappenberger L
    Int J Cardiol; 2003 Aug; 90(2-3):229-38. PubMed ID: 12957756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers for viral gene delivery.
    Wang C; Pham PT
    Expert Opin Drug Deliv; 2008 Apr; 5(4):385-401. PubMed ID: 18426381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes.
    Kapturczak MH; Flotte T; Atkinson MA
    Curr Mol Med; 2001 May; 1(2):245-58. PubMed ID: 11899074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vectors for in vivo gene delivery to vascular tissue.
    White K; Nicklin SA; Baker AH
    Expert Opin Biol Ther; 2007 Jun; 7(6):809-21. PubMed ID: 17555367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated viral vectors and the retina.
    Alexander JJ; Hauswirth WW
    Adv Exp Med Biol; 2008; 613():121-8. PubMed ID: 18188936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus-based vectors in gene therapy.
    Tal J
    J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism.
    Lagor WR; Johnston JC; Lock M; Vandenberghe LH; Rader DJ
    Methods Mol Biol; 2013; 1027():273-307. PubMed ID: 23912992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells.
    Wang C
    J Neurovirol; 2008 Nov; 14(6):563-8. PubMed ID: 18991069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits.
    Lattermann C; Oxner WM; Xiao X; Li J; Gilbertson LG; Robbins PD; Kang JD
    Spine (Phila Pa 1976); 2005 Mar; 30(5):497-504. PubMed ID: 15738780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss: Vector overcomes barrier to gene therapy delivery.
    Kingwell K
    Nat Rev Drug Discov; 2017 Mar; 16(4):238-239. PubMed ID: 28356584
    [No Abstract]   [Full Text] [Related]  

  • 17. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
    Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
    J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vectrology of adeno-associated viruses (AAV).
    Skubis-Zegadło J; Stachurska A; Małecki M
    Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical modification of recombinant adenovirus-associated virus vectors].
    Zhang D; Qiu F; Diao Y
    Bing Du Xue Bao; 2013 Sep; 29(5):566-72. PubMed ID: 24386848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assaying the Stability and Inactivation of AAV Serotype 1 Vectors.
    Howard DB; Harvey BK
    Hum Gene Ther Methods; 2017 Feb; 28(1):39-48. PubMed ID: 28192678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.